We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Neurontin Class Action V. Pfizer Dismissed

Law360 (April 3, 2009, 12:00 AM EDT) -- A federal judge has dismissed a consolidated class action accusing Pfizer Inc. of a scheme to use patent litigation to delay generic competition for the epilepsy drug Neurontin, after the end-payor plaintiffs voluntarily dropped their claims against the pharmaceutical giant.

Judge Faith S. Hochberg tossed a total of 17 cases on Thursday in the U.S. District Court for the District of New Jersey, where litigation against Pfizer and its Warner-Lambert Co. subsidiary has been pending since 2002.

Beginning on Feb. 26, end-payor plaintiffs began to knock...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.